| Serial Number | 79439106 |
| Word Mark | SPLICEMATRIX |
| Filing Date | Friday, August 29, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, May 11, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | SPLICE MATRIX |
| Goods and Services | Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for pharmaceutical drug development for medical and veterinary purposes; development of medical and veterinary preparations; scientific research, namely, screening for the identification of drug candidates for scientific research purposes; development of precision RNA therapeutic pharmaceuticals; medical research in the nature of the development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; medical research in the nature of the development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; Drug screening for scientific research purposes, Scientific research relating to bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); Scientific research relating to designing and implementing multiplexed high-throughput assays to screen for small molecules that modulate RNA processing using bioinformatic tools. |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Contera Pharma A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Event Date | Event Description |
| Thursday, December 11, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, December 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, December 14, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, January 13, 2026 | ASSIGNED TO EXAMINER |
| Friday, January 23, 2026 | NON-FINAL ACTION WRITTEN |
| Saturday, January 24, 2026 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, February 19, 2026 | REFUSAL PROCESSED BY MPU |
| Friday, February 20, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, March 12, 2026 | REFUSAL PROCESSED BY IB |
| Monday, May 11, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 11, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 11, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |